Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

[Dabigatran and emergency operation on a peritonitis patient].

Ilmakunnas M, Louhimo J, Lassila R.

Duodecim. 2012;128(7):753-7. Review. Finnish.

PMID:
22612026
2.

Dabigatran and bleeding: still an emergent situation?

Van Heukelom J, Lal Y.

Am J Med Sci. 2013 Sep;346(3):259. doi: 10.1097/MAJ.0b013e3182960987. No abstract available.

PMID:
23698156
3.

Reversal of a dabigatran overdose: what are possible options?

Ratanapo S, Ungprasert P, Srivali N, Cheungpasitporn W, Bischof EF.

Am J Med Sci. 2013 Sep;346(3):259. doi: 10.1097/MAJ.0b013e318295cc72. No abstract available.

PMID:
23974270
4.

Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

Berger R, Salhanick SD, Chase M, Ganetsky M.

Ann Emerg Med. 2013 Apr;61(4):475-9. doi: 10.1016/j.annemergmed.2013.02.008.

PMID:
23522810
5.

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.

Lillo-Le Louët A, Wolf M, Soufir L, Galbois A, Dumenil AS, Offenstadt G, Samama MM.

Thromb Haemost. 2012 Sep;108(3):583-5. doi: 10.1160/TH12-03-0149. Epub 2012 Jul 10. No abstract available.

PMID:
22782645
6.

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

Alikhan R, Rayment R, Keeling D, Baglin T, Benson G, Green L, Marshall S, Patel R, Pavord S, Rose P, Tait C.

Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22. Review.

7.

Dabigatran: patient management in specific clinical settings.

Kyrle PA, Binder K, Eichinger S, Függer R, Gollackner B, Hiesmayr JM, Huber K, Lang W, Perger P, Quehenberger P, Roithinger FX, Schmaldienst S, Weltermann A, Domanovits H.

Wien Klin Wochenschr. 2014 Sep;126(17-18):503-8. doi: 10.1007/s00508-014-0581-x. Epub 2014 Aug 20.

8.

Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.

Sølbeck S, Nilsson CU, Engström M, Ostrowski SR, Johansson PI.

Scand J Clin Lab Invest. 2014 Oct;74(7):591-8. doi: 10.3109/00365513.2014.921930. Epub 2014 Jun 9.

PMID:
24909158
9.

Dabigatran: life-threatening bleeding.

[No authors listed]

Prescrire Int. 2013 Feb;22(135):41-3. Review.

PMID:
23444501
10.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW.

J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. Review.

11.

Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity.

Dager WE, Gosselin RC, Roberts AJ.

Crit Care Med. 2013 May;41(5):e42-6. doi: 10.1097/CCM.0b013e31827caaa3.

PMID:
23474679
12.

Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.

Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF.

Am J Kidney Dis. 2013 Sep;62(3):591-4. doi: 10.1053/j.ajkd.2013.02.361. Epub 2013 Apr 16.

PMID:
23597859
13.

Bleeding risk with dabigatran in the frail elderly.

Harper P, Young L, Merriman E.

N Engl J Med. 2012 Mar 1;366(9):864-6. doi: 10.1056/NEJMc1112874. No abstract available.

14.

[Dabigatran therapy--perioperative management and interpretation of coagulation tests].

Spannagl M, Bauersachs R, Debus ES, Gawaz M, Gerlach H, Haas S, Hach-Wunderle V, Lindhoff-Last E, Riess H, Schellong S, Schinzel H, Bode C.

Hamostaseologie. 2012;32(4):294-305. doi: 10.5482/ha-2012030004. German.

PMID:
23114798
15.

Removal of dabigatran by hemodialysis.

Chang DN, Dager WE, Chin AI.

Am J Kidney Dis. 2013 Mar;61(3):487-9. doi: 10.1053/j.ajkd.2012.08.047. Epub 2012 Dec 5.

PMID:
23219111
16.

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Blood. 2012 Mar 1;119(9):2172-4. doi: 10.1182/blood-2011-11-393587. No abstract available.

17.

Risk of major bleeding and the standard doses of dabigatran.

Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.

Eur J Intern Med. 2014 Jul;25(6):e73-5. doi: 10.1016/j.ejim.2014.02.005. Epub 2014 Mar 11. No abstract available.

PMID:
24629895
18.

Dabigatran and postmarketing reports of bleeding.

Southworth MR, Reichman ME, Unger EF.

N Engl J Med. 2013 Apr 4;368(14):1272-4. doi: 10.1056/NEJMp1302834. Epub 2013 Mar 13. No abstract available.

19.

Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.

Matute MC, Guillán M, García-Caldentey J, Buisan J, Aparicio M, Masjuan J, Alonso de Leciñana M.

Thromb Haemost. 2011 Jul;106(1):178-9. doi: 10.1160/TH11-01-0042. Epub 2011 Apr 20. No abstract available.

PMID:
21505718
20.

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM.

Clin Toxicol (Phila). 2015 Mar;53(3):156-63. doi: 10.3109/15563650.2015.1004580. Epub 2015 Feb 8.

PMID:
25661675
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk